• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Sotatercept (Winrevair) Approved
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Generic Adcirca is Coming!

August 23, 2018 By Dr. Jeremy Feldman

generic medication

After many years under patent protection, the generic medication Tadalafil will soon be available. What does this mean for patients? Hopefully generic Tadalafil will be much less expensive than Adcirca.  We can look back at what happened with a similar medicine, Revatio, when it went generic as sildenafil. Pricing We don’t know precise pricing but we expect deep discounts … [Read more...]

Inhaled Nitric Oxide and PAH: Update

August 15, 2018 By Dr. Jeremy Feldman

blood cells pulmonary arteries

Bellerophon announced that their phase 3 clinical trial using portable nitric oxide in patients with PAH has been stopped.  The trial was stopped early after an analysis of data gathered so far showed no evidence of efficacy (the inhaled medication was not effective).  There did not appear to be a safety problem. This clinical trial was exciting as very low nitric oxide … [Read more...]

Entire Implantable System for Remodulin Approved by the FDA

July 31, 2018 By Dr. Jeremy Feldman

good news re PAH

It is finally here! The Food and Drug Administration approved Remodulin in its implantable delivery system for treatment of Pulmonary Arterial Hypertension. We have been providing updates on the 8-year study that investigated the use of an implanted pump to deliver Remodulin removing the need for external pumps and are excited to announce it is finally approved. The pump … [Read more...]

Is Vaping Safe with Lung Disease? No!

July 30, 2018 By Dr. Jeremy Feldman

vaping

Good Health Starts with Good Decisions Some things in life are under our control and others are not.  Patients with PAH or any other lung disease already have impaired lung function. Avoiding further lung damage is crucial to your health.  You and your doctor are probably working at improving your PAH through medications that cost a fortune.  What else can you do to help … [Read more...]

Important Update About Foundation Support

July 12, 2018 By Dr. Jeremy Feldman

News about PAH

Today two charitable foundations announced that they have reopened to help patients with PAH pay for their medications.  The Patient Advocate Foundation and the PAN Foundation are now accepting applications. See below for details. Patient Advocate Foundation has copay grants to individuals with Medicare, Medicaid or military insurance. You may apply online by clicking here or … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

CCCs for PAH

2017 PAH Comprehensive Care Center Update

By Dr. Jeremy Feldman

Since 2014 the Pulmonary Hypertension Association has been working to provide a more useful directory of PAH experts.

congenital heart disease atrial septal defect

FAQ’s: Oral Treatments, Care Centers & Hole in Heart

By Dr. Jeremy Feldman

Your Questions Answered Is there an oral treatment that can replace continuously infused therapy

good news in pah

 

Disclaimer

Recent Blog Posts

  • Making Order from Chaos October 26, 2025
  • Sotatercept: ZENITH and HYPERION Trials June 22, 2025
  • In Memoriam:  Greg Ahearn, MD June 16, 2024

Categories

Archives